Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer
Comparative Study Between Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer
Sponsor: Alexandria University
Listed as NCT04434677, this NA trial focuses on Breast Cancer and remains ongoing. Sponsored by Alexandria University, it has been updated 7 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
May 2021 — Apr 2023 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jul 2020 — Oct 2020 [monthly]
Recruiting NA
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alexandria University
For direct contact, visit the study record on ClinicalTrials.gov .